The CARE program from Business France selects the best French start-ups in eHealth for a tour in North America. After 2 months of a selection process involving pitches in front of a pannel of 16 US and Canadian experts, Medexprim was selected for this 2018 Tour. Thanks to this program, we will build long-lasting relationships with Canadian and US healthcare stakeholders. More information on https://events-export.businessfrance.fr/ecare/.
Overland Park, KS – US-based Softek Illuminate and the entrepreneurial French firm Medexprim announced today they will be combining, distributing and supporting each other’s product offerings as a unified solution for hospital researchers interested in exploiting previously unstructured clinical and image databases. The two companies will be featuring the other’s solutions at the Society for Imaging Informatics in Medicine (SIIM) Annual Meeting in National Harbour, Maryland, May 31- June 2 at their respective booths (Illuminate – #423; Medexprim -#104).
The 8 semi-finalists have been announced for the SIIM (Society for Imaging Informatics in Medicine) 2018 Innovation Challenge. Medexprim is proud that his project was selected and recognized by the medical imaging informatics community as one of the most impacting innovation in the field. Our project is entitled : “Unleash the potential of biomedical images archives and associated data for research and big data projects”.
Come and visit us at #SIIM2018 to know more.
More on the SIIM Innovation Challenge.
Cross4Health is an EU program that aims at leverageing technologies developed in the Aerospace and Energy industry for healthcare innovative solution. Medexprim won the third prize of the idea contest which was organized in Toulouse on Feb. 15 & 16, 2018. They took up a challenge proposed by a faxillo-facial surgeon and came up with the idea of building a new decision-aid and plannification software tool for faxillo-facial reconstruction. This tool will be built thanks to the retrospective analysis of many pre-operative and post-operative CT scans of patients, and the know-how of Inria in mathematical modeling and predictive analysis.
Medexprim combines the ArchiMed platform with its Radiomics Enabler® solution to facilitate the collection and management of imaging data in retrospective and prospective clinical studies.
Medexprim’s Radiomics Enabler®, meant to unleash the potential of medical images archives for research, is now released as open source software under a GNU Affero General Public License v3 (AGPLv3).
Medexprim is proud to have been selected to be part of the first ever RSNA Start-Up Showcase.
Come and visit us – North Hall B @ booth 6455B.
Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data.
The famous open-source clinical data warehouse community (see https://www.i2b2.org/) will hold its european academic meeting on Oct. 5 and 6 in Paris. To this occasion, Karine Seymour will present how Radiomics Enabler® can integrate with i2b2 or any other clinical data warehouse. By doing so, we extend clinical data warehousing with image extraction capabilities and enable population based radiomics studies. More information on the conference and program on http://blogs.aphp.fr/i2b2.
Karine Seymour, Medexprim’s founder was interviewed by DSIH Magazine. You can find the full content of the interview (in French) on DSIH’s web site.
If you would like to know more about Radiomics Enabler®, contact us. We will show you how you can eliminate cumbersome manual processes in Radiomics projects and enable your researchers to be at the forefront of the fast evolving imaging biomarker discovery area.